Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Capecitabine
Xeloda
Routinely available
SMC (34/03)
01/01/2000

Indication

Metastatic breast cancer

Metastatic breast cancer

Therapeutic Area

Malignant disease and immunosuppression

Status Description

Routinely available

Formulation

Tablets

Comments

Included in the Formulary.

Link to Advice

34/03

Advice Published

07/03/2003

SMC Submission Type

Full

SMC Status

Restricted